Abstract
Implicit in the discussion of bioethical issues in regards to Alzheimer’s disease is the question of the relationship of possible risk and expected benefit from further investigations. The most significant benefit to the person, the family, and to society would be a breakthrough in our understanding of a disease process that is at present not treatable and not preventable—a disease that is as malignant in its own way as cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. D. Terry and R. Katzman, “Senile Dementia of the Alzheimer’s Type,” Annals of Neurology14, 497–506, 1983.
R. Katzman, editor, “Biological Aspects of Alzheimer’s Disease,” Banbury Report15, New York, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 The Humana Press, Inc.
About this chapter
Cite this chapter
Katzman, R. (1985). Current Frontiers in Research on Alzheimer’s Disease. In: Melnick, V.L., Dubler, N.N. (eds) Alzheimer’s Dementia. Contemporary Issues in Biomedicine, Ethics, and Society. Humana Press. https://doi.org/10.1007/978-1-4612-5174-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5174-3_1
Publisher Name: Humana Press
Print ISBN: 978-1-4612-9597-6
Online ISBN: 978-1-4612-5174-3
eBook Packages: Springer Book Archive